John Kelly
Vermögen: 45 418 $ am 31.07.2026
Vermögen: 45 418 $ am 31.07.2026
John Kelly is the founder of Atomo Diagnostics Ltd., founded in 2010, where the title held was Chief Executive Officer, Director & MD from 2025 to 2026.
Mr. Kelly is currently a Non-Executive Director at Tetratherix Ltd. Formerly, Mr. Kelly was Chief Operating Officer at Unilife Corp.
Education includes undergraduate studies at The University of Liverpool, an MBA from The University of Sydney, and graduate studies at Queen's University Belfast A.F.C.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TETRATHERIX LIMITED 0,02 % | 30.06.2025 | 8.680 ( 0,02 % ) | 45 418 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TETRATHERIX LIMITED | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ATOMO DIAGNOSTICS LIMITED | Vorstandsvorsitzender | 19.08.2026 |
| UNILIFE CORPORATION | Geschäftsführer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Unilife Corp.
Unilife Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets syringes & other medical devices | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures and markets blood testing vitro diagnostic medical devices | Health Technology |
Queen's University Belfast A.F.C.
Queen's University Belfast A.F.C. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetratherix Pty Ltd.
Tetratherix Pty Ltd. Medical SpecialtiesHealth Technology Develops bio stealth fluid matrix and technology platform | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen